Cardiovascular Business February 26, 2025
Kestra Medical Technologies, a Washington-based medtech company known for its wearable heart monitors and defibrillators, is going public on the Nasdaq Global Select Market under the ticker symbol KMTS.
The company intends to sell 10 million common shares priced somewhere between $14 and $16 per share. Underwriters also have an over-allotment option to offer an additional 1.5 million common shares if necessary.
In total, Kestra predicts that this initial public offering will earn the company somewhere between $133 million and $155 million. Its plan is to use these proceeds to hire new sales representatives and clinical care specialists in addition to investing heavily in its supply chain and revenue cycle management capabilities.
BofA Securities, Goldman Sachs and...
Today's Sponsors
Today's Sponsor